en,pt,fr,tr,de,title,speaker,duration,tags
"
","
","
","
","
",A simple new blood test that can catch cancer early,Jimmy Lin,12:10,"biology,cancer,disease,DNA,health,epidemiology,innovation,medical research,medicine,TED Fellows,science"
"
											Cancer.
											Many of us have lost family,
friends or loved ones
											to this horrible disease.
											I know there are some of you
in the audience
											who are cancer survivors,
											or who are fighting cancer at this moment.
											My heart goes out to you.
											While this word often conjures up
emotions of sadness and anger and fear,
											I bring you good news
from the front lines of cancer research.
											The fact is, we are starting to win
the war on cancer.
											In fact, we lie at the intersection
											of the three of the most exciting
developments within cancer research.
									","
											O cancro.
											Muitos de nós já perdemos familiares,
amigos ou entes queridos
											para esta terrível doença.
											Sei que há aqui na audiência
											quem seja sobrevivente do cancro,
											ou que estão a lutar com um cancro
neste momento.
											O meu coração está convosco.
											Embora esta palavra evoque
emoções de tristeza, de raiva e de medo,
											eu trago-vos boas notícias da primeira
linha da investigação do cancro.
											Estamos a começar a vencer
a guerra contra o cancro.
											Na realidade, estamos na encruzilhada
											de três das evoluções mais animadoras
na investigação do cancro.
									","
											Le cancer.
											Beaucoup d'entre nous ont perdu
des amis ou des êtres chers
											à cause de cette horrible maladie.
											Je sais qu'il y a certains d'entre vous
											qui ont survécu au cancer,
											ou qui se battent
contre le cancer en ce moment.
											Je suis de tout coeur avec vous.
											Si ce mot évoque souvent la tristesse,
la colère et la peur,
											je vous apporte de bonnes nouvelles
des premières lignes de la recherche.
											Le fait est que l'on commence à gagner
la lutte contre le cancer.
											En fait, on se situe à la croisée
											de trois développements majeurs
dans la recherche contre le cancer.
									","
											Kanser.
											Çoğumuz bu korkunç hastalıktan
dolayı sevdiklerini,
											aike ve arkadaşlarını kaybetti.
											Şu an aranızda,
dinleyicilerden kanser olanların,
											kanserden kurtulanların
											veya kanserle olduğunu biliyorum.
											Sizi çok iyi anlıyorum.
											Bu dünya korku, öfke ve hüzün
gibi duyguları bir ayara getirse de
											kanser tedavisi için çok
güzel haberlerim var sizlere.
											Gerçek şu ki biz kansere açtığımız
savaşı kazanmaya başlıyoruz.
											Aslında biz kanser araştırmasının
											en heyecanlı 3 gelişmesinin
tam ortasında duruyoruz.
									","
											Krebs.
											Viele von uns haben Familienmitglieder, 
Freunde oder Angehörige
											an diese schreckliche Krankheit verloren.
											Ich weiß, 
dass einige von Ihnen im Publikum
											den Krebs überlebt haben
											oder gerade gegen Krebs ankämpfen.
											Wir fühlen mit Ihnen.
											Dieses Wort ruft oft Gefühle der Trauer, 
Wut und Angst hervor.
											Ich bringe jedoch gute Nachrichten von 
der vordersten Front der Krebsforschung.
											Tatsache ist: Wir beginnen, 
den Krieg gegen den Krebs zu gewinnen.
											In der Tat befinden 
wir uns am Schnittpunkt
											der drei spannendsten Entwicklungen 
innerhalb der Krebsforschung.
									",A simple new blood test that can catch cancer early,Jimmy Lin,12:10,"biology,cancer,disease,DNA,health,epidemiology,innovation,medical research,medicine,TED Fellows,science"
"
","
","
","
","
",A simple new blood test that can catch cancer early,Jimmy Lin,12:10,"biology,cancer,disease,DNA,health,epidemiology,innovation,medical research,medicine,TED Fellows,science"
"
											The first is cancer genomics.
											The genome is a composition
											of all the genetic information
encoded by DNA
											in an organism.
											In cancers, changes
in the DNA called mutations
											are what drive these cancers
to go out of control.
											Around 10 years ago,
I was part of the team at Johns Hopkins
											that first mapped
the mutations of cancers.
											We did this first for colorectal,
											breast, pancreatic and brain cancers.
											And since then, there have been
over 90 projects in 70 countries
											all over the world,
											working to understand
the genetic basis of these diseases.
											Today, tens of thousands
of cancers are understood
											down to exquisite molecular detail.
									","
											A primeira é a genómica do cancro.
											O genoma é uma composição
											de todas as informações genéticas
codificadas pelo ADN
											num organismo.
											Nos cancros, as alterações
no ADN, chamadas mutações,
											são o que faz com que estes cancros
fiquem fora de controlo,
											Há cerca de 10 anos,
fiz parte da equipa no John Hopkins
											que foi a primeira a mapear
as mutações dos cancros,
											Primeiro, fizemos isso
para os cancros do cólon,
											da mama, do pâncreas e do cérebro.
											Desde então, tem havido mais
de 90 projetos em 70 países,
											pelo mundo inteiro,
											que trabalham para compreender
a base genética destas doenças.
											Hoje, conhecemos dezenas
de milhares de cancros
											até ao mais requintado pormenor molecular.
									","
											Le premier est le cancer génomique.
											Le génome est la composition
											de toute l'information génétique
encodée par l'ADN
											dans un organisme.
											Dans un cancer, les changements
dans l'ADN sont appelés mutations
											et font que le cancer devienne
hors de contrôle.
											Il y a environ 10 ans, j'ai fait partie
de l'équipe à Johns Hopkins
											qui a été la première à cartographier
les mutations du cancer.
											Nous l'avons fait pour
le cancer colorectal,
											le cancer du sein, 
du pancréas et du cerveau.
											Et depuis, il y a eu
plus de 90 projets dans 70 pays
											partout dans le monde,
											qui travaillent à comprendre
la base génétique de cette maladie.
											Aujourd'hui, des dizaines de milliers
de cancers sont expliqués
											jusqu'à un niveau exquis 
de détail moléculaire.
									","
											İlki kanser genetiği.
											Genom, bir organizmadaki
											DNA tarafından kodlanmış
											genetik bir kod bileşiğidir.
											Kanserde kontrolden çıkan şey,
											mutasyon adı verilen,
DNA'da meydana gelen değişiklikler.
											10 yıl önce ben Johns Hopkins'te
											kanserdeki mutasyonları
belirleyen takımdaydım.
											Bunu ilk olarak kolon, mide,

											göğüs, pankreas 
ve beyin kanserleri için yaptık.
											O zamandan beri bu hastalığın
genetik temelini anlamak için
											dünya çapında,
											70 ülkeden 90 proje yapıldı.
											Günümüzde, on binlerce kanser
hassas moleküler yapılarına kadar
											anlaşılabiliyor.
									","
											Die Erste ist die Krebsgenomik.
											Das Genom ist die Zusammensetzung
											der gesamten in DNA verschlüsselten 
genetischen Information
											eines Organismus.
											Beim Krebs sind es Veränderungen
in der DNA, sogenannte Mutationen,
											die dazu führen,
dass der Krebs außer Kontrolle gerät.
											Vor etwa 10 Jahren
war ich Teil eines Teams
											am John-Hopkins-Krankenhaus,
											das Krebsmutationen
zum ersten Mal entschlüsselte.
											Dies taten wir als erstes 
für kolorektalen,
											Brust- und Pankreaskrebs 
sowie Gehirntumore.
											Seitdem gab es auf der ganzen Welt
											über 90 Projekte in 70 Ländern
											mit dem Ziel, die genetischen Grundlagen 
dieser Erkrankungen zu verstehen.
											Heute verstehen wir 
zehntausende Krebsarten
											auf molekularer Ebene 
außergewöhnlich genau.
									",A simple new blood test that can catch cancer early,Jimmy Lin,12:10,"biology,cancer,disease,DNA,health,epidemiology,innovation,medical research,medicine,TED Fellows,science"
"
","
","
","
","
",A simple new blood test that can catch cancer early,Jimmy Lin,12:10,"biology,cancer,disease,DNA,health,epidemiology,innovation,medical research,medicine,TED Fellows,science"
"
											The second revolution
is precision medicine,
											also known as ""personalized medicine.""
											Instead of one-size-fits-all methods
to be able to treat cancers,
											there is a whole new class of drugs
that are able to target cancers
											based on their unique genetic profile.
											Today, there are a host
of these tailor-made drugs,
											called targeted therapies,
											available to physicians even today
											to be able to personalize
their therapy for their patients,
											and many others are in development.
									","
											A segunda revolução
é a medicina de precisão,
											também conhecida
por ""medicina personalizada"".
											Em vez de métodos de utilização geral
para tratarmos cancros,
											há toda uma nova classe de medicamentos
que conseguem atingir os cancros
											com base no seu perfil genético especial.
											Hoje, há uma imensidade
destes medicamentos por medida,
											chamados terapias dirigidas,
											já disponíveis aos médicos
											que podem personalizar
a sua terapia para os doentes
											e há muitos outros em desenvolvimento.
									","
											La seconde révolution est
la médecine de précision,
											dite aussi 
« médecine personnalisée ».
											Au lieu d'utiliser des méthodes génériques
pour traiter les cancers,
											il y a une nouvelle classe de médicaments
capable de cibler les cancers
											basés sur leur profil génétique unique.
											Aujourd'hui, il y a une multitude
de ces médicaments sur mesure,
											appelés thérapies ciblées,
											déjà accessibles aux médecins aujourd'hui
											qui permettent de personnaliser
leurs thérapies pour leurs patients,
											et bien d'autres sont 
en train d'être développées.
									","
											İkinci madde ise
""hassas tıp.""
											diğer adıyla ""kişiselleştirilmiş tıp"".
											Kanser tedavisindeki
tek tip ilaçlar yerine,
											eşsiz genetik yapılarına göre 
farklı kanserleri hedef alan
											yepyeni bir dizi ilaç var.
											Bugün hedeflenmiş terapi denen
											kişiye özel ilaçları
											kullanan bir sürü taşıyıcı var.
											Bunlar kendi terapi ilaçlarını
ve gelişmekte olan ilaçları
											deneyip özelleştirmeye yarıyorlar.
									","
											Die zweite Revolution ist 
die Präzisionsmedizin,
											auch bekannt als 
""personalisierte Medizin"".
											Anstelle von Standardbehandlungen 
für Krebserkrankungen
											gibt es eine neue Klasse
von Arzneimitteln,
											die Krebserkrankungen basierend auf ihren
einzigartigen genetischen Profilen
											angreifen können.
											Heute stehen Ärzten schon viele
dieser maßgeschneiderten Arzneimittel,
											sogenannte ""zielgerichtete Therapien"",
zur Verfügung,
											um die Therapie ihrer 
Patienten zu personalisieren.
											Viele andere befinden sich 
in der Entwicklung.
									",A simple new blood test that can catch cancer early,Jimmy Lin,12:10,"biology,cancer,disease,DNA,health,epidemiology,innovation,medical research,medicine,TED Fellows,science"
"
","
","
","
","
",A simple new blood test that can catch cancer early,Jimmy Lin,12:10,"biology,cancer,disease,DNA,health,epidemiology,innovation,medical research,medicine,TED Fellows,science"
"
											The third exciting revolution
is immunotherapy,
											and this is really exciting.
											Scientists have been able
to leverage the immune system
											in the fight against cancer.
											For example, there have been ways
where we find the off switches of cancer,
											and new drugs have been able
to turn the immune system back on,
											to be able to fight cancer.
											In addition, there are ways
where you can take away immune cells
											from the body,
											train them, engineer them
and put them back into the body
											to fight cancer.
											Almost sounds like
science fiction, doesn't it?
									","
											A terceira revolução animadora
é a imunoterapia
											que é realmente animadora.
											Os cientistas têm conseguido
equilibrar o sistema imunitário
											na luta contra o cancro.
											Por exemplo, há formas de podermos
encontrar os interruptores do cancro
											e há novos medicamentos que permitem
voltar a ligar o sistema imunitário
											para este poder combater o cancro.
											Além disso, há formas de podermos
retirar células imunitárias do corpo,
											treiná-las, modificá-las
e voltarmos a colocá-las no corpo
											para combater o cancro.
											Até parece ficção científica, não é?
									","
											La troisième révolution passionnante
est l'immunothérapie,
											et elle est fascinante.
											Des scientifiques ont réussi
à influencer le système immunitaire
											dans le combat contre le cancer.
											Par exemple, il y a eu des techniques
où l'on trouve le bouton off du cancer
											et que de nouveaux médicaments
réactivent le système immunitaire,
											afin que celui-ci combatte le cancer.
											De plus, il y a des techniques où l'on
peut retirer des cellules immunitaires
											du corps,
											les entraîner, les façonner
et les replacer dans le corps
											pour combattre le cancer.
											On dirait de la science-fiction,
n'est-ce pas ?
									","
											Üçüncü heyecan verici etken ise
""immünoterapi""
											ve bu gerçekten heyecan verici.
											Bilim, bağışıklık sistemini 
kanserle savaşması için
											düzenlemeyi başardılar.
											Mesela, kanserin kapatma tuşunu
bulmamızı sağlayan bir çok yol var.
											Yeni ilaçlar da bağışıklık sistemini
aktive ederek
											kanserle savaşmasını sağlıyor.
											Ek olarak, vücuttaki bağışıklık
hücrelerini alıp
											eğitip değiştirerek
											kanserler savaşması 
için vücuda geri göndermenin
											bir çok yolu var.
											Tam bir bilimkurgu filmi
gibi geliyor, değil mi ?
									","
											Die dritte aufregende Entwicklung 
ist die Immuntherapie.
											Das ist wirklich spannend.
											Wissenschaftlern ist es gelungen,
das Immunsystem zu nutzen,
											um den Krebs zu bekämpfen.
											Zum Beispiel haben wir einige 
Aus-Schalter des Krebs gefunden
											und neue Arzneimittel sind in der Lage, 
das Immunsystem wieder anzuschalten,
											so dass es den Krebs bekämpfen kann.
											Außerdem ist es möglich,
											Immunzellen aus dem Körper zu entnehmen,
											sie zu trainieren und zu manipulieren, 
und sie zurück in den Körper zu geben,
											um den Krebs zu bekämpfen.
											Das hört sich fast an
wie Science Fiction, oder?
									",A simple new blood test that can catch cancer early,Jimmy Lin,12:10,"biology,cancer,disease,DNA,health,epidemiology,innovation,medical research,medicine,TED Fellows,science"
"
","
","
","
","
",A simple new blood test that can catch cancer early,Jimmy Lin,12:10,"biology,cancer,disease,DNA,health,epidemiology,innovation,medical research,medicine,TED Fellows,science"
"
											While I was a researcher
at the National Cancer Institute,
											I had the privilege of working
with some of the pioneers of this field
											and watched the development firsthand.
											It's been pretty amazing.
											Today, over 600 clinical trials are open,
											actively recruiting patients
to explore all aspects in immunotherapy.
									","
											Quando eu fazia investigação
no Instituto Nacional do Cancro,
											tive o privilégio de trabalhar
com alguns dos pioneiros nesta área
											e observei diretamente a evolução.
											Tem sido muito excitante.
											Hoje, estão em curso
mais de 600 experiências clínicas,
											que recrutam doentes
											para explorarem todos os aspetos
na imunoterapia.
									","
											Quand j'étais chercheur
à l'Institut National du Cancer,
											j'ai eu le privilège de travailler
avec certains pionniers dans ce domaine
											et j'ai vu la révolution 
de mes propres yeux.
											C'était vraiment incroyable.
											Aujourd'hui, plus de 600 essais cliniques
sont en cours,
											recrutant des patients pour explorer 
tous les aspects de l'immunothérapie.
									","
											Ulusal Kanser Enstitüsü'nde çalışırken
											alanında uzman kişilerle
çalışma ayrıcalığına sahip oldum
											ve çalışmaları yakından izleyebildim.
											Çok etkileyiciydi.
											Aktif olarak çalışan hastaların
immünuterapiyi anlamaları için
											bugün 600'ün üzerinde
deneme yapılıyor.
									","
											Als ich als Wissenschaftler am 
National Cancer Institute tätig war,
											durfte ich mit einigen der Pioniere
in diesem Bereich arbeiten
											und diese Entwicklungen
aus erster Hand beobachten.
											Es war wirklich staunenswert.
											Heute gibt es über 600 
aktive klinische Studien,
											die Patienten rekrutieren, um alle 
Aspekte der Immuntherapie zu untersuchen.
									",A simple new blood test that can catch cancer early,Jimmy Lin,12:10,"biology,cancer,disease,DNA,health,epidemiology,innovation,medical research,medicine,TED Fellows,science"
"
","
","
","
","
",A simple new blood test that can catch cancer early,Jimmy Lin,12:10,"biology,cancer,disease,DNA,health,epidemiology,innovation,medical research,medicine,TED Fellows,science"
"
											While these three exciting
revolutions are ongoing,
											unfortunately, this is only the beginning,
											and there are still many, many challenges.
											Let me illustrate with a patient.
											Here is a patient
with a skin cancer called melanoma.
											It's horrible; the cancer
has gone everywhere.
											However, scientists were able
to map the mutations of this cancer
											and give a specific treatment
that targets one of the mutations.
											And the result is almost miraculous.
											Tumors almost seem to melt away.
											Unfortunately, this is not
the end of the story.
											A few months later, this picture is taken.
											The tumor has come back.
											The question is: Why?
											The answer is tumor heterogeneity.
											Let me explain.
									","
											Embora estas três revoluções
animadoras estejam em curso,
											infelizmente, estamos apenas no início,
											e ainda há muitos problemas.
											Vou ilustrar com um doente.
											Este é um doente
com um cancro de pele chamado melanoma.
											É horrível: o cancro
espalhou-se por toda a parte.
											[Antes do tratamento]
											No entanto, os cientistas conseguiram
mapear as mutações deste cancro
											e fazer um tratamento específico
que se dirige a uma das mutações.
											[Após tratamento]
											O resultado é quase milagroso.
											Os tumores até parecem
ter-se derretido.
											Infelizmente, isto não é
o fim da história.
											Uns meses depois,
tirou-se esta fotografia.
											O tumor regressou.
											A pergunta é: Porquê?
											A resposta é a heterogeneidade do tumor.
											Passo a explicar.
									","
											Tandis que ces trois passionnantes
révolutions sont en cours,
											ce n'est malheureusement que le début,
											il faut encore faire face
à de nombreux défis.
											Laissez-moi vous l'illustrer 
avec un patient.
											Voici un patient avec un cancer 
de la peau, appelé mélanome.
											C'est horrible: le cancer s'est répandu
dans tout le corps.
											Cependant, les scientifiques ont pu
cartographier les mutations de ce cancer
											et établir un traitement spécifique 
qui cible l'une des mutations.
											Le résultat est presque miraculeux.
											On a l'impression que les 
tumeurs disparaissent.
											Malheureusement, 
ce n'est pas la fin de l'histoire.
											Plusieurs mois après, 
cette photo a été prise.
											Le tumeur est revenue.
											La question est : pourquoi?
											La réponse est dans 
l’hétérogénéité de la tumeur.
											Laissez-moi m'expliquer.
									","
											Bu harika 3 çalışmaya devam ediliyor
											fakat ne yazık ki bu sadece başlangıç,
											hala çözmemiz gereken
bir sürü sorun var.
											Bir hasta ile size resmedeyim.
											Melanoma adında bir deri 
kanserine yakalanmış bir hasta var.
											Korkunç bir şey! 
Kanser her tarafa yayılmış.
											Ancak bilim insanları 
bu mutasyonu düzenleyip
											özel olarak geliştirdiler
ve hastalara özel tedavide uyguladılar.
											Sonuç neredeyse mucizeviydi.
											Tümörler neredeyse eriyip gidiyordu.
											Ne yazık ki bu hikayenin sonu değil.
											Birkaç ay sonra bu fotoğraf çekildi.
											Tümör geri dönmüş.
											Asıl soru ise ""Neden ?""
											Cevabı: ""tümör heterojenliği""
											Açıklamama izin verin.
									","
											Trotz dieser drei aufregenden Revolutionen
											ist das leider nur der Anfang.
											Es gibt immer noch 
sehr viele Herausforderungen.
											Lassen Sie mich das
anhand eines Patienten verdeutlichen.
											Hier ist ein Patient mit Hautkrebs, 
einem sogenannten Melanom.
											Es ist schrecklich; 
der Krebs hat sich überall verbreitet.
											Wissenschaftler konnten jedoch die
Mutationen dieses Krebses entschlüsseln
											und eine besondere Behandlung einleiten, 
die auf eine der Mutationen abzielt.
											Und das Ergebnis ist fast ein Wunder.
											Die Tumore scheinen 
beinahe wegzuschmelzen.
											Leider ist die Geschichte 
hier noch nicht vorbei.
											Einige Monate später 
wurde dieses Bild gemacht.
											Der Tumor ist zurückgekommen.
											Die Frage ist: Warum?
											Die Antwort lautet: Tumorheterogenität.
											Lassen Sie mich erklären.
									",A simple new blood test that can catch cancer early,Jimmy Lin,12:10,"biology,cancer,disease,DNA,health,epidemiology,innovation,medical research,medicine,TED Fellows,science"
"
","
","
","
","
",A simple new blood test that can catch cancer early,Jimmy Lin,12:10,"biology,cancer,disease,DNA,health,epidemiology,innovation,medical research,medicine,TED Fellows,science"
"
											Even a cancer as small
as one centimeter in diameter
											harbors over a hundred million
different cells.
											While genetically similar,
											there are small differences
in these different cancers
											that make them differently prone
to different drugs.
											So even if you have a drug
that's highly effective,
											that kills almost all the cells,
											there is a chance
that there's a small population
											that's resistant to the drug.
											This ultimately is the population
											that comes back,
											and takes over the patient.
									","
											Mesmo um cancro pequeno,
apenas com um centímetro de diâmetro,
											aberga mais de cem milhões
de células diferentes.
											Embora geneticamente semelhantes,
											há pequenas diferenças 
nestes cancros diferentes
											que reagem de modo diferente
a diferentes medicamentos.
											Mesmo que tenhamos um medicamento
extremamente eficaz
											que mate quase todas as células,
											há sempre a possibilidade
de haver uma pequena população
											que seja resistente a esse medicamento.
											Por fim, é essa população
											que regressa e invade o doente.
									","
											Même un cancer faisant 
un centimètre de diamètre
											héberge des centaines 
de cellules différentes.
											Même s'ils sont génétiquement similaires,
											ces cancers présentent 
de petites différences
											qui les fait réagir différemment
aux divers médicaments.
											Donc, même si vous avez 
un médicament très efficace,
											qui tue presque toutes les cellules,
											il existe une possibilité 
qu'une petite population
											soit résistante à ce médicament.
											Au bout du compte, c'est cette population
											qui revient,
et qui prend le dessus sur le patient.
									","
											Çapı 1 santimetre olan bir kanser bile
											yüz milyonlarca hücre barındırabiliyor.
											Genetik olarak benzer
olmalarına rağmen,
											Bu küçük farklı hücreler,
özelleşmeye başlıyor.
											Bu da farklı ilaçlara karşı 
zayıf olmalarına neden oluyor.
											Yani bütün kanser hücrelerini
yok edebilecek
											bir ilaç olsa bile
											çok küçük bir kısmın,
											bu ilaca direnebilme ihtimali var.
											Problem olan kısım ise
											geri dönen hücrelerin
											hastayı ele geçirmesi.
									","
											Auch ein Krebs von nur 
einem Zentimeter Durchmesser
											besteht aus über hundert Millionen 
unterschiedlicher Zellen.
											Trotz genetischer Ähnlichkeiten
											gibt es kleine Unterschiede zwischen 
den verschiedenen Krebserkrankungen,
											so dass sie auf unterschiedliche 
Arzneimittel ansprechen.
											Selbst bei einem 
hocheffektiven Arzneimittel,
											das fast alle Zellen abtötet,
											ist es möglich, 
dass eine kleine Population
											resistent gegen das Arzneimittel ist.
											Das ist letztendlich die Population,
die zurückkommt
											und die Kontrolle über 
den Patienten übernimmt.
									",A simple new blood test that can catch cancer early,Jimmy Lin,12:10,"biology,cancer,disease,DNA,health,epidemiology,innovation,medical research,medicine,TED Fellows,science"
"
","
","
","
","
",A simple new blood test that can catch cancer early,Jimmy Lin,12:10,"biology,cancer,disease,DNA,health,epidemiology,innovation,medical research,medicine,TED Fellows,science"
"
											So then the question is:
What do we do with this information?
											Well, the key, then,
											is to apply all these exciting
advancements in cancer therapy earlier,
											as soon as we can,
											before these resistance clones emerge.
											The key to cancer and curing cancer
is early detection.
											And we intuitively know this.
											Finding cancer early
results in better outcomes,
											and the numbers show this as well.
											For example, in ovarian cancer,
if you detect cancer in stage four,
											only 17 percent of the women
survive at five years.
											However, if you are able to detect
this cancer as early as stage one,
											over 92 percent of women will survive.
											But the sad fact is, only 15 percent
of women are detected at stage one,
											whereas the vast majority, 70 percent,
are detected in stages three and four.
									","
											Portanto, a questão é:
O que fazer com esta informação?
											Aí, o fundamental
											é aplicar todos estes avanços
na terapia do cancro, mais cedo,
											o mais depressa possível,
											antes de essa resistência surgir.
											O segredo para a cura do cancro
é a deteção precoce.
											Sabemos isso intuitivamente.
											Descobrir um cancro bem cedo
resulta em melhores resultados
											e os números também confirmam isso.
											Por exemplo, num cancro do ovário,
se detetarmos o cancro na fase quatro.
											só 17% das mulheres
sobrevivem cinco anos.
											Mas, se conseguirmos detetar
este cancro logo na fase um,
											mais de 92% das mulheres sobreviverão.
											Infelizmente, só 15% das mulheres
são detetadas na fase um,
											enquanto a grande maioria, 70%,
são detetadas nas fases três e quatro.
									","
											On peut poser la question : 
que faire avec cette information?
											Eh bien, la clé est
											d'appliquer au plus tôt ces découvertes 
passionnantes dans la thérapie du cancer,
											dès que l'on peut,
											avant que ces clones résistants émergent.
											La clé pour soigner le cancer est 
le dépistage précoce.
											Et nous le savons de façon intuitive.
											Le dépistage précoce
permet d'obtenir de meilleurs résultats,
											et les chiffres le démontrent.
											Par exemple, pour le cancer des ovaires,
si on le dépiste au stade 4,
											seules 17% des femmes 
survivent au-delà de 5 ans.
											Mais, si on arrive à détecter le cancer 
lorsqu'il est au stade 1,
											plus de 92% des femmes survivront.
											Malheureusement, seuls 15% des femmes 
sont dépistées au premier stade,
											alors que la grande majorité, 70%,
est dépistée au stade 3 et 4.
									","
											O zaman sorumuz şu olmalı:
Bu bilgiyle ne yapacağız?
											İşte anahtar sözcük,
											bu tedavileri erken teşhis
süresinde uygulayabilmek.
											En kısa sürede
											bu direnç hücreleri çoğalmadan önce.
											Kanser tedavisindeki en önemli nokta:
""erken teşhis.""
											Bunu öngörümüzle bilebiliyoruz.
											Kanseri erken teşhis etmenin
çok büyük yararları oluyor.
											Sayılar da bunu bize ispatlıyor.
											Mesela rahim kanserinde,
kanser eğer 4. aşamada tespit edilirse
											kadınların sadece %17'si
kurtulmayı başarabiliyor.
											Ancak siz bu kanseri ilk aşamasında
teşhis edebilirseniz,
											%92'nin üzerinde bir kısım kurtulabiliyor.
											Kötü haber ise sadece bunların %15'i
kanserin ilk aşamasında tespit ediliyor.
											Ne yazık ki diğer çok büyük %70'lik kısım
3 veya 4. aşamada tespit edilebiliyor.
									","
											Die Frage lautet nun: 
Was machen wir mit dieser Information?
											Der Schlüssel ist,
											alle diese aufregenden Fortschritte 
der Krebstherapie früher einzusetzen,
											so früh wir können,
											bevor diese Resistenzen aufkommen.
											Der Schlüssel zum Krebs und 
dessen Heilung ist die Früherkennung.
											Und intuitiv wissen wir das.
											Die Früherkennung von Krebs 
liefert bessere Ergebnisse.
											Die Zahlen zeigen das auch.
											Wird zum Beispiel Eierstockkrebs 
im Stadium vier erkannt,
											sind nur 17 Prozent der Frauen
nach fünf Jahren noch am Leben.
											Wird dieser Krebs jedoch
im Stadium eins erkannt,
											überleben über 92 Prozent der Frauen.
											Leider wird der Krebs nur bei 15 Prozent 
der Frauen in Stadium eins erkannt
											und bei den meisten, 70 Prozent, 
in Stadium drei und vier.
									",A simple new blood test that can catch cancer early,Jimmy Lin,12:10,"biology,cancer,disease,DNA,health,epidemiology,innovation,medical research,medicine,TED Fellows,science"
"
","
","
","
","
",A simple new blood test that can catch cancer early,Jimmy Lin,12:10,"biology,cancer,disease,DNA,health,epidemiology,innovation,medical research,medicine,TED Fellows,science"
"
											We desperately need
better detection mechanisms for cancers.
											The current best ways to screen cancer
fall into one of three categories.
											First is medical procedures,
											which is like colonoscopy
for colon cancer.
											Second is protein biomarkers,
like PSA for prostate cancer.
											Or third, imaging techniques,
											such as mammography for breast cancer.
											Medical procedures are the gold standard;
											however, they are highly invasive
											and require a large
infrastructure to implement.
											Protein markers, while effective
in some populations,
											are not very specific
in some circumstances,
											resulting in high numbers
of false positives,
											which then results in unnecessary work-ups
and unnecessary procedures.
											Imaging methods,
while useful in some populations,
											expose patients to harmful radiation.
											In addition, it is not applicable
to all patients.
											For example, mammography has problems
in women with dense breasts.
									","
											Precisamos, urgentemente, de melhores
mecanismos de deteção dos cancros.
											A melhor forma, atualmente, de detetar
um cancro cai em três categorias.
											Primeira, procedimentos médicos,
											como a colonoscopia
para o cancro do cólon.
											Segundo, biomarcadores proteicos,
como o PSA, para o cancro da próstata.
											E terceiro, técnicas de imagiologia,
											como a mamografia,
para o cancro da mama.
											Os procedimentos médicos são
o padrão de ouro;
											contudo, são altamente invasivos
											e exigem uma grande infraestrutura
para os realizar.
											Os marcadores proteicos,
embora eficazes nalgumas populações,
											não são muito específicos
em certas circunstâncias,
											resultando em números elevados
de falsos positivos
											que depois resultam em trabalhos
e procedimentos desnecessários.
											Os métodos de imagiologia
embora úteis nalgumas populações,
											sujeitam os doentes
a radiações prejudiciais.
											Para além disso, não são aplicáveis
a todos os doentes.
											Por exemplo, a mamografia tem problemas
nas mulheres com seios densos.
									","
											Nous avons besoin de meilleures
techniques pour dépister le cancer.
											Il existe actuellement 3 moyens afin de
dépister au mieux le cancer.
											Premièrement, il y a
les procedures médicales,
											c'est-à-dire la coloscopie 
pour le cancer du côlon.
											Deuxièmement, les biomarqueurs de protéine,
comme le PSA pour le cancer de la prostate.
											Ou troisièmement, l'imagerie médicale,
											comme la mammographie 
pour le cancer du sein.
											Les procédures médicales 
sont la référence absolue ;
											cependant, elles sont très invasives
											et demandent de grandes
infrastructures pour être mises en place.
											Les marqueurs de protéine, même si
efficaces pour certaines personnes,
											ne sont pas assez précis 
dans certaines circonstances,
											ce qui donne
de grands nombres de faux positifs,
											qui conduisent à des examens et 
des procédures inutiles.
											L'imagerie médicale,
bien qu'utile pour certaines personnes,
											expose les patients à 
des radiations nocives.
											En plus, elle ne convient pas 
à tout patient.
											Par exemple, la mammographie n'est pas
adaptée pour les tissus mammaires denses.
									","
											Aşırı derecede daha iyi tespit 
mekanizmalarına ihtiyacımız var.
											Şu an kanseri en iyi görüntülemenin
üç yolundan birini kullanıyoruz.
											İlk yolu medikal süreç,
											kolon kanseri için
kolonoskopi yapmak mesela.
											İkincisi ise protein biyolojisi,
prostat kanseri için PSA olabilir.
											Veya üçüncüsü, resimleme teknikleri.
											Göğüs kanseri için mamografi örneği.
											Bu tarz medikal süreçler
altın değerindedir.
											Ancak bunlar çok invazif olabiliyor
											ve ayrıca zamanda yapabilmek için
bir altyapı gerekiyor.
											Protein işaretçileri her ne kadar
bazı kesimlerde etkili olsa da
											bazı durumlarda yetersiz kalabiliyor,
											yanlış pozitif sonuçlara yol açabiliyor.
											Sonra da bir çok gereksiz prosedür
ve çalışma yapılmasına neden oluyor.
											Resimleme teknikleri ise
bazı yerlerde çok kullanışlı olsa da
											Hastaları zararlı radyasyona 
maruz bırakıyor.
											Ek olarak, her hastaya uygulanabilen
bir yöntem değil.
											Mesela mamografi, büyük göğüslü 
kadınlarda bazı problemlere yol açabilir.
									","
											Wir brauchen unbedingt bessere 
Erkennungsmethoden für Krebserkrankungen.
											Die zur Zeit besten Methoden 
des Krebs-Screenings
											fallen in eine der drei 
folgenden Kategorien:
											Erstens: medizinische Eingriffe,
											wie zum Beispiel die 
Kolonoskopie bei Darmkrebs.
											Zweitens: Protein-Biomarker, 
wie PSA für Prostatakrebs.
											Und drittens: bildgebende Verfahren,
											wie die Mammographie für Brustkrebs.
											Medizinische Eingriffe 
sind der Goldstandard;
											sie sind jedoch sehr invasiv
											und benötigen eine umfangreiche 
Infrastruktur für die Durchführung.
											Protein-Biomarker sind effektiv
in einigen Populationen,
											jedoch in manchen Fällen 
nicht sehr spezifisch,
											was zu vielen falsch-positiven 
Ergebnissen führt,
											so dass es zu unnötigen Untersuchungen 
und Eingriffen kommen kann.
											Bildgebende Verfahren sind zwar 
nützlich in einigen Populationen,
											setzen die Patienten jedoch 
schädlicher Strahlung aus.
											Zudem sind sie nicht 
bei allen Patienten einsetzbar.
											So funktioniert zum Beispiel 
die Mammographie
											bei dichtem Brustgewebe 
nicht ohne Probleme.
									",A simple new blood test that can catch cancer early,Jimmy Lin,12:10,"biology,cancer,disease,DNA,health,epidemiology,innovation,medical research,medicine,TED Fellows,science"
"
","
","
","
","
",A simple new blood test that can catch cancer early,Jimmy Lin,12:10,"biology,cancer,disease,DNA,health,epidemiology,innovation,medical research,medicine,TED Fellows,science"
"
											So what we need is a method
that is noninvasive,
											that is light in infrastructure,
											that is highly specific,
											that also does not have false positives,
											does not use any radiation
											and is applicable to large populations.
											Even more importantly,
											we need a method
to be able to detect cancers
											before they're 100 million cells in size.
											Does such a technology exist?
											Well, I wouldn't be up here
giving a talk if it didn't.
									","
											Portanto, precisamos de um método
que não seja invasivo,
											que seja ligeiro
quanto às infraestruturas,
											que seja altamente específico,
											que também não tenha falsos positivos,
											que não use radiações
											e seja aplicável a grandes populações.
											E, ainda mais importante,
											precisamos de um método
capaz de detetar cancros
											antes de atingirem o tamanho
de 100 milhões de células.
											Existirá uma tecnologia assim?
											Eu não estaria aqui
a fazer esta palestra, se não existisse.
											(Risos)
									","
											Ainsi, nous avons besoin
d'une méthode non-invasive,
											dont l'infrastructure est légère,
											qui est très précise,
											et qui ne produit pas 
de faux positifs,
											qui n'utilise pas de radiation,
											et qui est applicable à 
la majorité de la population.
											Et surtout,
nous avons besoin d'une méthode
											qui puisse dépister les cancers
											avant qu'ils dépassent la taille de
100 millions de cellules.
											Est-ce qu'une technique pareille existe ?
											Eh bien, je ne serais pas là à faire
ce discours si ce n'était pas le cas.
									","
											Yani bizim ihtiyacımız 
olan zararsız bir yöntem;
											altyapıda ışık,
											oldukça spesifik,
											yanlış pozitif sonuç vermeyen,
											radyasyon kullanmayan,
											ve büyük nüfuslara uygulanabilen
bir yöntem.
											Daha da önemlisi,
											İhtiyacımız olan
100 milyon hücreye ulaşmadan
											kanseri tespit edebilecek bir yöntem.
											Böyle bir teknoloji var mı?
											Eğer olmasaydı bu konuşmayı yapmazdım.
									","
											Deswegen brauchen wir eine Methode, 
die nicht-invasiv ist,
											ohne viel Infrastruktur auskommt,
											hoch-spezifisch ist,
											keine falsch-positiven Ergebnisse erzielt,
											keine Strahlung einsetzt
											und bei großen Populationen 
eingesetzt werden kann.
											Am wichtigsten ist,
											dass die Methode Tumore aufspüren kann
											bevor sie eine Größe von 
hundert Millionen Zellen erreichen.
											Existiert so eine Technologie?
											Wenn es sie nicht gäbe, 
würde ich heute keinen Vortrag halten.
									",A simple new blood test that can catch cancer early,Jimmy Lin,12:10,"biology,cancer,disease,DNA,health,epidemiology,innovation,medical research,medicine,TED Fellows,science"
"
","
","
","
","
",A simple new blood test that can catch cancer early,Jimmy Lin,12:10,"biology,cancer,disease,DNA,health,epidemiology,innovation,medical research,medicine,TED Fellows,science"
"
											I'm excited to tell you about
this latest technology we've developed.
											Central to our technology
is a simple blood test.
											The blood circulatory system,
while seemingly mundane,
											is essential for you to survive,
											providing oxygen
and nutrients to your cells,
											and removing waste and carbon dioxide.
											Here's a key biological insight:
											Cancer cells grow and die
faster than normal cells,
											and when they die,
											DNA is shed into the blood system.
											Since we know the signatures
of these cancer cells
											from all the different cancer
genome sequencing projects,
											we can look for those signals in the blood
											to be able to detect these cancers early.
											So instead of waiting for cancers
to be large enough to cause symptoms,
											or for them to be dense enough
to show up on imaging,
											or for them to be prominent enough
											for you to be able to visualize
on medical procedures,
											we can start looking for cancers
while they are relatively pretty small,
											by looking for these small amounts
of DNA in the blood.
									","
											Tenho o prazer de vos falar
											desta última tecnologia
que estamos a desenvolver.
											No centro da nossa tecnologia
está uma simples análise ao sangue.
											O sistema sanguíneo circulatório,
embora aparentemente banal.
											é essencial para sobrevivermos,
											fornecendo oxigénio
e nutrientes às células
											e removendo os desperdícios
e o dióxido de carbono.
											Esta é uma perspetiva
biológica fundamental.
											As células cancerosas crescem e morrem
mais depressa que as células normais
											e, quando morrem, o ADN é lançado
no sistema sanguíneo.
											Como conhecemos as assinaturas
dessas células cancerosas,
											de todos os diferentes projetos
de sequenciamento do genoma canceroso,
											podemos procurar esses sinais no sangue
											para conseguir detetar
precocemente esses cancros.
											Em vez de esperar que os cancros sejam
bastante grandes para causar sintomas,
											ou que sejam bastante densos
para aparecerem na imagiologia,
											ou que sejam suficientemente volumosos
											para poderem ser visualizados
por procedimentos médicos,
											podemos começar a procurar cancros
enquanto eles são relativamente pequenos,
											observando estas pequenas quantidades
de ADN no sangue.
									","
											Je suis heureux de vous parler de
la technique que nous avons développée.
											Le coeur de notre technique réside
en un simple test sanguin.
											Le système de circulation sanguine,
même s'il paraît banal,
											est essentiel à votre survie,
											en fournissant oxygène
et nutriments à vos cellules,
											et en éliminant les déchets et le
dioxyde de carbone.
											Voici une vision biologique importante :
											les cellules cancéreuses grandissent et
meurent plus vite que les cellules normales,
											et quand elles meurent,
											leur ADN se répand dans le
système cardiovasculaire.
											Puisqu'on connaît les signatures 
de ces cellules cancéreuses
											grâce aux différents projets de séquençage
des génomes du cancer,
											nous pouvons chercher 
ces signaux dans le sang
											afin de dépister ces cancers au plus tôt.
											Au lieu d'attendre que les cancers soient
assez grands pour causer des symptômes,
											ou assez denses pour
être visible sur l'imagerie,
											ou assez visibles
											pour qu'ils puissent être vus
lors de procédures médicales,
											nous pouvons commencer à chercher les
cancers encore relativement petits,
											en cherchant ces petites quantités
d'ADN dans le sang.
									","
											Son geliştirdiğimiz teknolojiyi
sizlere anlatmak için çok heyecanlıyım.
											Teknolojimizin merkezinde
basit bir kan tahlili var.
											Dolaşım sistemi 
ne kadar sıradan gözükse de
											yaşamımız için çok önemli,
											hücrelerinize oksijen ve besin sağlıyor,
											atık ve karbondioksiti uzaklaştırıyorlar.
											Bir biyolojik püf nokta:
											Kanser hücreleri normal hücrelerden
daha hızlı büyür ve ölür,
											öldükleri zaman ise
											DNA kana karışır.
											Biz bu kanser hücrelerinin
işaretlerini bildiğimiz için
											farklı kanser genom düzenleme
projeleri sayesinde
											kanda bu işaretlere bakabiliyoruz,
											böylece kanseri erkenden
teşhis edebiliyoruz.
											Yani kanserlerin semptomlara
sebep olacak kadar büyümelerini
											veya belirginleşecek kadar 
yoğunlaşmalarını
											ya da medikal süreçte
görüntülenebilir olması için
											göze çarpmalarını beklemek yerine,
											hala çok küçük olsalar da biz bu
kanser hücrelerini aramaya başlıyoruz,
											Bunu da kanda o bahsettiğim
küçük miktarda DNA'yı arayarak yapıyoruz.
									","
											Ich freue mich, Ihnen von
den neuesten Technologien zu erzählen,
											die wir entwickelt haben.
											Der wesentliche Bestandteil unserer 
Technologie ist ein einfacher Bluttest.
											Unser Blutkreislaufsystem 
scheint zwar banal,
											ist aber lebenswichtig;
											es versorgt unsere Zellen mit 
Sauerstoff und Nährstoffen
											und entfernt Abfallstoffe 
und Kohlendioxid.
											Hier ist eine wichtige 
biologische Erkenntnis:
											Krebszellen wachsen und sterben 
schneller als normale Zellen
											und wenn sie sterben,
											wird DNA in den Blutkreislauf freigesetzt.
											Da wir die Signaturen der Krebszellen
											von den verschiedenen Krebsgenom-
Sequenzierungsprojekten kennen,
											können wir diese Signale im Blut suchen,
											um diese Krebserkrankungen 
frühzeitig zu erkennnen.
											Anstatt also darauf zu warten,
											dass der Krebs groß genug ist, 
um Symptome zu verursachen,
											oder dicht genug, 
um auf einem Bild sichtbar zu sein,
											oder auffällig genug ist,
											um durch einen medizinischen 
Eingriff erkannt zu werden,
											können wir nach dem Krebs suchen, 
während er noch klein ist,
											indem wir nach diesen kleinen Mengen
von DNA im Blut suchen.
									",A simple new blood test that can catch cancer early,Jimmy Lin,12:10,"biology,cancer,disease,DNA,health,epidemiology,innovation,medical research,medicine,TED Fellows,science"
"
","
","
","
","
",A simple new blood test that can catch cancer early,Jimmy Lin,12:10,"biology,cancer,disease,DNA,health,epidemiology,innovation,medical research,medicine,TED Fellows,science"
"
											So let me tell you how we do this.
											First, like I said, we start off
with a simple blood test —
											no radiation, no complicated equipment —
											a simple blood test.
											Then the blood is shipped to us,
											and what we do
is extract the DNA out of it.
											While your body is mostly healthy cells,
											most of the DNA that's detected
will be from healthy cells.
											However, there will be a small amount,
less than one percent,
											that comes from the cancer cells.
											Then we use molecular biology methods
to be able to enrich this DNA
											for areas of the genome which are known
to be associated with cancer,
											based on the information
from the cancer genomics projects.
											We're able to then put this DNA
into DNA-sequencing machines
											and are able to digitize the DNA
into A's, C's, T's and G's
											and have this final readout.
											Ultimately, we have information
of billions of letters
											that output from this run.
											We then apply statistical
and computational methods
											to be able to find
the small signal that's present,
											indicative of the small amount
of cancer DNA in the blood.
									","
											Vou explicar como fazemos isso.
											Primeiro, começamos
com uma simples análise ao sangue
											— sem radiações,
sem equipamentos complicados —
											uma simples análise ao sangue.
											Depois o sangue é-nos enviado
											e nós extraímos-lhe o ADN.
											Como o nosso corpo é sobretudo
formado por células saudáveis,
											a maior parte do ADN que detetamos
será de células saudáveis.
											Mas haverá uma pequena quantidade
— menos de 1% —
											que provém das células cancerosas.
											Depois, usamos métodos
de biologia molecular
											para enriquecer este ADN
											nas áreas do genoma que, sabemos,
estão associadas ao cancro,
											com base nas informações
dos projetos genómicos do cancro.
											Conseguimos assim colocar este ADN
nas máquinas de sequenciação do ADN
											e conseguimos digitalizar o ADN
em A, C, T e G
											e ter esta leitura final.
											Por fim, temos a informação
de milhares de milhões de letras
											que resultam deste processo.
											Depois aplicamos métodos
estatísticos e informáticos
											para conseguirmos encontrar
o mais pequeno sinal presente,
											indicador da pequena quantidade
de ADN canceroso no sangue.
									","
											Laissez-moi expliquer
comment on fait.
											Premièrement, nous commençons
avec une simple prise de sang —
											pas de radiation, pas d'équipement
compliqué —
											une simple prise de sang.
											Ensuite, le sang nous est envoyé,
											et nous extrayons l'ADN 
de ce test sanguin.
											Alors que le corps est composé
de cellules en bonne santé,
											la plupart de l'ADN détecté
proviendra de cellules en bonne santé.
											Il y aura quand-même une petite partie,
moins d'1%,
											qui proviendra des cellules cancéreuses.
											Ensuite on utilise des méthodes 
de biologie moléculaire
											afin d'enrichir cet ADN
											pour les endroits du génome qui sont
connus pour être associées au cancer,
											selon les informations des 
projets des génomes du cancer.
											Ensuite, nous mettons
cet ADN dans les machines de séquençage
											et nous pouvons numériser
l'ADN en A, C, T et G
											afin d'avoir la lecture finale.
											Pour finir, nous avons des information 
de milliards de lettres
											qui ressortent de cette série.
											Ensuit, nous appliquons des méthodes
statistiques et informatiques
											afin de trouver
le petit signal présent,
											qui indique une petite quantité d'ADN
du cancer dans le sang.
									","
											Nasıl yaptığımızı anlatayım.
											İlk olarak dediğim gibi basit
bir kan tahlili ile başlıyoruz.
											Radyasyon veya teknik ekipman yok,
											basit bir kan tahlili
											Daha sonra kan bize ulaştığında,
											yaptığımız şey DNA'yı kandan ayırmak.
											Vücudunuzun çoğu sağlıklı hücreler
olduğundan dolayı
											Tespit edilen DNA'nın çoğu da
sağlıklı hücrelerden oluyor.
											fakat küçük bir miktar DNA,
hatta 1%'den daha da düşük,
											bu kanserli hücrelerden geliyor.
											Sonra bu DNA'yı güçlendirmek için
kanserle bağlantılı genom kısımlarında
											kanser genonu projelerinden
elde ettiğimiz bilgiye dayanarak
											moleküler biyoloji 
yöntemleri kullanıyoruz.
											Elde ettiğimiz DNA'yı
DNA eşleme makinesine koyuyoruz.
											Bu sayede DNA'yı
A,C,T,G bileşenlerine ayırabiliyor
											ve son çıktıyı alabiliyoruz.
											Sonuç olarak
bu süreçten çıkan milyarlarca
											bilgi mektubu elde ediyoruz.
											Daha sonra biz istatistik
ve hesaplama yöntemleri kullanarak
											bu küçük işaretleri bulmaya çalışıyoruz,
											Kanın içindeki küçük kanser DNA'sı
sayesinde kanseri tespit edebiliyoruz.
									","
											Und so funktioniert es:
											Wie gesagt, beginnen wir als 
erstes mit einem einfachen Bluttest –
											keine Strahlung, 
kein kompliziertes Equipment –
											ein einfacher Bluttest.
											Das Blut wird an uns geliefert
											und wir extrahieren die DNA.
											Da der Körper hauptsächlich 
aus gesunden Zellen besteht,
											ist der Großteil der erfassten 
DNA von gesunden Zellen.
											Es gibt jedoch eine kleine Menge, 
weniger als ein Prozent,
											die von Krebszellen stammt.
											Wir benutzen dann 
molekularbiologische Methoden,
											um die Teile der DNA zu vervielfältigen,
											die bekannterweise 
mit Krebs assoziiert sind,
											basierend auf den Informationen 
der Krebsgenom-Projekte.
											Dann können wir die DNA
mittels DNA-Sequenzier-Geräten
											digital als As, Cs, Ts und Gs darstellen
											und kriegen diese finale Anzeige.
											Letztendlich erhalten wir Informationen 
in Form von Milliarden von Buchstaben
											als Ergebnis dieser Untersuchung.
											Dann benutzen wir statistische
und rechnergestützte Methoden,
											um das kleine Signal zu finden,
											das auf eine kleine Menge 
Krebs-DNA hinweist.
									",A simple new blood test that can catch cancer early,Jimmy Lin,12:10,"biology,cancer,disease,DNA,health,epidemiology,innovation,medical research,medicine,TED Fellows,science"
"
","
","
","
","
",A simple new blood test that can catch cancer early,Jimmy Lin,12:10,"biology,cancer,disease,DNA,health,epidemiology,innovation,medical research,medicine,TED Fellows,science"
"
											So does this actually work in patients?
											Well, because there's no way
of really predicting right now
											which patients will get cancer,
											we use the next best population:
											cancers in remission;
											specifically, lung cancer.
											The sad fact is, even with the best drugs
that we have today,
											most lung cancers come back.
											The key, then, is to see
											whether we're able to detect
these recurrences of cancers
											earlier than with standard methods.
									","
											Será que isto funciona
em doentes?
											Como não há forma de prever
neste momento
											que pacientes irão ter um cancro,
											usamos a população
com cancros em remissão;
											especificamente, o cancro do pulmão.
											Infelizmente, mesmo com os melhores
medicamentos de que dispomos hoje,
											a maior parte dos cancros de pulmão
regressa.
											O importante é ver
											se conseguimos detetar
essa recorrência de cancros
											mais cedo do que os métodos atuais.
									","
											Alors, est-ce que ça fonctionne
réellement avec des patients ?
											Eh bien, comme il n'est vraiment possible
de prévoir maintenant
											quels patients attraperont le cancer,
											nous utilisons ceux 
qui s'en rapprochent le plus :
											les cancers en remission ;
											et plus spécifiquement, 
le cancer du poumon.
											Malheureusement, même avec les meilleurs
médicaments d'aujourd'hui,
											la plupart des cancers du poumon 
reviennent.
											L'élément important est de voir
											si nous sommes capables de dépister
ces cancers récurrents
											plus tôt qu'avec des méthodes standard.
									","
											Peki bu gerçekten hastalar 
üzerinde işe yarıyor mu?
											Şu anda hangi hastaların 
kanser olacağını
											gerçekten öngöremesek de
											En iyi ikinci popülasyonu kullanıyoruz:
											hafifleme düzeyindeki kanser,
											özellikle karaciğer kanseri.
											Üzücü olan şey en iyi ilaçları 
kullanmamıza rağmen
											çoğu akciğer kanser geri dönüyor.
											Asıl kilit nokta ise
											biz bu kanserin geri dönüşünü
diğer standart metotlardan
											daha hızlı tespit edebiliyoruz.
									","
											Und funktioniert das 
wirklich in Patienten?
											Da wir zur Zeit keine 
Möglichkeit haben, vorherzusagen
											welche Patienten an 
Krebs erkranken werden,
											benutzen wir die nächstbeste Population:
											Krebs in Remission,
											genauer gesagt, Lungenkrebs.
											Sogar mit den besten Arzneimitteln, 
die es heutzutage gibt,
											kommen leider die meisten 
Lungenkrebse zurück.
											Das Entscheidende ist herauszufinden,
											ob wir die Rückkehr des Krebses 
früher entdecken können
											als mit Standardmethoden.
									",A simple new blood test that can catch cancer early,Jimmy Lin,12:10,"biology,cancer,disease,DNA,health,epidemiology,innovation,medical research,medicine,TED Fellows,science"
"
","
","
","
","
",A simple new blood test that can catch cancer early,Jimmy Lin,12:10,"biology,cancer,disease,DNA,health,epidemiology,innovation,medical research,medicine,TED Fellows,science"
"
											We just finished a major trial
											with Professor Charles Swanton
at University College London,
											examining this.
											Let me walk you through
an example of one patient.
											Here's an example of one patient
who undergoes surgery
											at time point zero,
											and then undergoes chemotherapy.
											Then the patient is under remission.
											He is monitored using clinical exams
and imaging methods.
											Around day 450, unfortunately,
the cancer comes back.
											The question is:
Are we able to catch this earlier?
											During this whole time,
we've been collecting blood serially
											to be able to measure
the amount of ctDNA in the blood.
											So at the initial time point, as expected,
											there's a high level
of cancer DNA in the blood.
											However, this goes away to zero
in subsequent time points
											and remains negligible
after subsequent points.
											However, around day 340, we see the rise
of cancer DNA in the blood,
											and eventually, it goes up higher
for days 400 and 450.
									","
											Acabámos há pouco uma grande experiência
											com o Professor Charles Swanton
no University College London,
											examinando isto.
											Vou mostrar-vos um exemplo de um doente.
											Este é o exemplo de um doente
que sofre uma cirurgia
											no ponto zero
											e depois, passa pela quimioterapia.
											Depois, o doente está em remissão.
											É acompanhado, usando exames clínicos
e métodos de imagiologia.
											Por volta do dia 450, infelizmente,
o cancro regressa.
											A questão é:
Podíamos detetá-lo mais cedo?
											Durante todo este tempo,
recolhemos amostras de sangue
											para podermos medir a quantidade
de ADN canceroso no sangue.
											No ponto inicial, conforme esperado,
											há um alto nível de ADN
canceroso no sangue.
											Mas este passa a zero
na subsequente etapa de tempo
											e mantém-se negligenciável
depois dessas etapas.
											Contudo, por volta do dia 340,
											vemos o aumento do ADN
canceroso no sangue,
											e, por fim, vai subindo
durante os dias 400 e 450.
									","
											Nous venons de terminer 
un essai majeur
											avec le professeur Charles Swanton à
l'University College de Londres,
											à ce sujet.
											Laissez-moi vous montrer un exemple
avec un patient.
											C'est l'exemple d'un patient qui
recourt à la chirurgie
											à un moment donné,
											et doit ensuite recourir
à la chimiothérapie.
											Ensuite, le patient 
se trouve en rémission.
											Il est surveillé à l'aide d'examens
cliniques et de l'imagerie médicale.
											Autour du 450ème jour, malheureusement,
le cancer revient.
											La question est : est-on
capables de le dépister avant ?
											Pendant tout ce temps, nous avons
collecté continuellement du sang
											afin de mesurer la 
quantité de ADNct dans le sang.
											Donc, au point de départ, comme prévu,
											il y a un grand niveau d'ADN
cancéreux dans le sang.
											Cependant, il disparaît ensuite
											et reste négligeable 
après plusieurs mesures .
											Cependant, autour du 340ème jour,
											nous voyons la montée de l'ADN cancéreux 
dans le sang,
											et pour finir, il remonte entre le 400
et le 450ème jour.
									","
											Büyük bir denemeyi yeni bitirdik,
											London Üniversite'sinden
Profesör Charles Swanton'la birlikte
											bu projeyi inceledik.
											Bir hasta örneğini size 
anlatmama izin verin.
											Burada ameliyat geçiren bir hastanın
											sıfırdan örneği var
											ve sonra kemoterapi alıyor.
											Hastalığın hafifleme süreci
											klinik ekipmanlar ve projeksiyon
yöntemleri kullanılarak resmedildi.
											Yaklaşık 450. günde ne yazık ki
kanser nüksetti.
											Soru şu:
Bu kanseri önceden tespit edebilir miydik?
											Bütün zaman boyunca
düzenli olarak kan aldık.
											Kandaki ctDNA miktarını ölçmek için
											İlk başta beklediğimiz üzere,
											Kanda yüksek miktarda 
kanser DNA'sı bulunuyordu.
											Ancak daha sonraki periyotlarda
bu miktar sıfıra doğru ilerliyor,
											diğer zamanlarda da ihmal edilebilecek
kadar küçük miktarlar.
											Ancak 340. gün civarında kandaki
kanser DNA'sının yükselişini görebiliriz.
											En sonunda, 400 ve 450. günler arasında
daha da yükseliyor.
									","
											Wir haben gerade
eine große klinische Studie
											mit Professor Charles Swanton
am University College London beendet,
											die das untersuchte.
											Lassen Sie es mich das anhand
eines Patienten genauer erklären.
											Hier ist ein Beispiel eines Patienten, 
der zum Zeitpunkt Null operiert wird
											und dann eine Chemotherapie erhält.
											Der Patient ist dann in Remission.
											Er wird durch klinische Untersuchungen
und bildgebende Verfahren beobachtet.
											Um den Tag 450 herum 
kommt der Krebs leider zurück.
											Die Frage ist: 
Können wir das früher erkennen?
											Die ganze Zeit über 
nahmen wir regelmäßig Blut ab,
											um die Menge an Krebs-DNA
im Blut zu bestimmen.
											Wie erwartet, ist am ersten Zeitpunkt
											die Krebs-DNA Menge im Blut hoch.
											Die Menge nimmt jedoch
zu den nachfolgenden Zeitpunkten ab
											und verschwindet fast vollständig 
zu späteren Zeitpunkten.
											Etwa am Tag 340 sehen wir einen 
Anstieg von Krebs-DNA im Blut
											und letztendlich einen noch höheren 
Anstieg an den Tagen 400 und 450.
									",A simple new blood test that can catch cancer early,Jimmy Lin,12:10,"biology,cancer,disease,DNA,health,epidemiology,innovation,medical research,medicine,TED Fellows,science"
"
","
","
","
","
",A simple new blood test that can catch cancer early,Jimmy Lin,12:10,"biology,cancer,disease,DNA,health,epidemiology,innovation,medical research,medicine,TED Fellows,science"
"
											Here's the key, if you've missed it:
											At day 340, we see the rise
in the cancer DNA in the blood.
											That means we are catching this cancer
over a hundred days earlier
											than traditional methods.
											This is a hundred days earlier
where we can give therapies,
											a hundred days earlier
where we can do surgical interventions,
											or even a hundred days less
for the cancer to grow
											or a hundred days less
for resistance to occur.
											For some patients, this hundred days
means the matter of life and death.
											We're really excited
about this information.
									","
											O segredo está aqui, se bem repararam.
											No dia 340, vemos o aumento
no ADN do cancro no sangue.
											Isso significa que detetámos
este cancro mais de cem dias antes
											do que os métodos tradicionais.
											São cem dias mais cedo
em que podemos fazer terapia,
											cem dias mais cedo em que podemos
fazer intervenções cirúrgicas,
											cem dias menos
para o cancro se desenvolver
											ou cem dias menos
para ocorrer uma resistência.
											Para alguns doentes, estes cem dias
são uma questão de vida ou morte.
											Estamos muito animados
com esta informação.
									","
											Voilà la clé de l'histoire, 
si vous l'avez manquée :
											au 340ème jour, nous voyons la montée de
l'ADN cancéreux dans le sang.
											Cela signifie qu'on dépiste ce cancer
plus d'une centaine de jours
											avant les méthodes traditionnelles.
											C'est cent jours plus tôt,
où l'on peut donner des médicaments,
											cent jours plut tôt,
où l'on peut faire de la chirurgie,
											ou même cent jours de moins,
où le cancer ne grandit pas
											ou cent jours de moins,
où la résistance se produit.
											Pour certains patients, ces cent jours
sont une question de vie ou de mort.
											Nous sommes vraiment heureux
de cette information.
									","
											Eğer kaçırdıysanız anahtar kelime burada,
											340. gün civarında kandaki DNA miktarının
yükselişini görebiliyoruz.
											Bu demek oluyor ki
geleneksel metotlardan 100 gün önce
											kanseri tespit edebildik.
											Bu 100 gün öncesinde
terapiler yapabiliyorduk.
											100 gün önceden
cerrahi işlemler yapabiliyorduk
											veya kanserin iyileşmesi için
											veya tepkime olmadan önce
100 gün kazandık.
											Bazı hastalar için bu 100 gün
ölüm kalım meselesidir.
											Biz bu bilgiyle gerçekten 
çok heyecanlandık.
									","
											Hier ist das Entscheidende, 
falls Sie es verpasst haben:
											Am Tag 340 sehen wir einen 
Anstieg der Krebs-DNA im Blut.
											Das bedeutet, wir erkennen den Krebs 
mehr als hundert Tage früher
											als traditionelle Methoden.
											Das gibt uns hundert mehr 
Tage für Behandlungen,
											hundert mehr Tage für Operationen,
											hundert weniger Tage für 
das Wachstum des Krebses
											und hundert weniger Tage 
für das Auftreten von Resistenzen.
											Für manche Patienten machen diese 
hundert Tage Leben oder Tod aus.
											Diese Informationen haben uns begeistert.
									",A simple new blood test that can catch cancer early,Jimmy Lin,12:10,"biology,cancer,disease,DNA,health,epidemiology,innovation,medical research,medicine,TED Fellows,science"
"
","
","
","
","
",A simple new blood test that can catch cancer early,Jimmy Lin,12:10,"biology,cancer,disease,DNA,health,epidemiology,innovation,medical research,medicine,TED Fellows,science"
"
											Because of this assignment,
we've done additional studies now
											in other cancers,
											including breast cancer, lung cancer
											and ovarian cancer,
											and I can't wait to see how much earlier
we can find these cancers.
									","
											Na sequência desta investigação
fizemos estudos adicionais
											noutros cancros,
											incluindo cancro da mama,
cancro do pulmão e cancro do ovário.
											Estou ansioso por saber
com quanta antecedência
											conseguimos descobrir estes cancros.
									","
											Grâce à tout cela, nous avons
fait des recherches additionnelles
											sur d'autres cancers,
											y compris le cancer du sein, du poumon
											et des ovaires,
											et je suis impatient de voir
											avec combien d'avance 
nous dépisterons ces cancers
									","
											Çünkü bu görevlendirme yüzünden
diğer kanser türlerinde
											ek çalışmalar yaptık,
											göğüs kanseri dahil olmak üzere,
karaciğer kanseri,
											rahim kanseri,
											bu kanserleri de erkenden teşhis
edebilme umuduyla sabırsızlanıyorum.
									","
											Diesen Erkenntnissen folgten weitere 
Studien in anderen Krebsarten,
											einschließlich Brustkrebs,
Lungenkrebs und Eierstockkrebs.
											Ich kann es nicht erwarten zu sehen,
											wieviel früher wir
diese Krebsarten finden können.
									",A simple new blood test that can catch cancer early,Jimmy Lin,12:10,"biology,cancer,disease,DNA,health,epidemiology,innovation,medical research,medicine,TED Fellows,science"
"
","
","
","
","
",A simple new blood test that can catch cancer early,Jimmy Lin,12:10,"biology,cancer,disease,DNA,health,epidemiology,innovation,medical research,medicine,TED Fellows,science"
"
											Ultimately, I have a dream,
											a dream of two vials of blood,
											and that, in the future, as part of all
of our standard physical exams,
											we'll have two vials of blood drawn.
											And from these two vials of blood
we will be able to compare
											the DNA from all known
signatures of cancer,
											and hopefully then detect cancers
months to even years earlier.
											Even with the therapies we have currently,
											this could mean that millions
of lives could be saved.
											And if you add on to that
recent advancements in immunotherapy
											and targeted therapies,
											the end of cancer is in sight.
									","
											Por fim, eu tenho um sonho,
											um sonho com dois frasquinhos de sangue:
											que, no futuro, incluídos 
em todos os exames físicos de rotina
											nos recolham dois frasquinhos de sangue.
											A partir desses dois frasquinhos de sangue
poderemos comparar
											o ADN de todas as assinaturas
conhecidas de cancro,
											e detetar cancros, com a antecedência
de meses ou mesmo de anos.
											Mesmo com as terapias
de que dispomos hoje,
											isso pode significar que
poderemos salvar milhões de vidas.
											Se a isso acrescentarmos
os recentes progressos na imunoterapia
											e as terapias dirigidas,
											temos à vista o fim do cancro.
									","
											Pour finir, j'ai un rêve,
											un rêve de deux fioles de sang,
											et qu'un jour, dans le futur, dans tous
nos examens médicaux standard,
											on nous prendra deux fioles de sang.
											Et à partir de ces deux fioles de sang,
nous pourrons comparer
											l'ADN de toutes les signatures
des cancers,
											et dépister les cancers des mois,
voire des années plus tôt.
											Même avec les thérapies
que nous avons actuellement,
											cela signifie que des millions de vies
pourraient être sauvées.
											Si vous ajouter à cela les récentes
avancées en immunothérapie,
											et en thérapies ciblées,
											la fin du cancer est proche.
									","
											Sonuç olarak bir hayalim var,
											İki şişe kan ile ilgili bir hayal,
											gelecekte bizim standart fiziksel 
muayenelerimizin bir parçası gibi
											iki tüp alınmış kanımız var.
											Bu iki şişe kan ile DNA'dan
											tüm kanser belirtilerini
karşılaştırabiliyoruz
											ve umuyorum ki bu kanserleri aylar önce
hatta yıllar önce tespit edebiliyoruz.
											Şu anki terapilerimizle birlikte bile,
											milyonlarca hayat kurtarılabilir demek bu.
											İmmünoterapi'deki son gelişmeler
ve hedef terapileri de
											buna eklerseniz,
											Kanserin sonu göründü demektir.
									","
											Schlussendlich habe ich den Traum
											von zwei Blutröhrchen
											und dass in der Zukunft als Teil unserer 
normalen körperlichen Untersuchungen
											zwei Röhrchen Blut abgenommen werden.
											Mithilfe dieser zwei 
Blutröhrchen werden wir
											die DNA aller bekannten 
Krebs-Signaturen vergleichen können
											und hoffentlich Krebserkrankungen 
Monate oder sogar Jahre früher aufspüren.
											Selbst mit den aktuell 
verfügbaren Therapien
											könnten so Millionen 
von Leben gerettet werden.
											Und rechnet man hierzu noch die 
neuesten Fortschritte in der Immuntherapie
											und den zielgerichteten Therapien hinzu,
											ist das Ende des Krebses nahe.
									",A simple new blood test that can catch cancer early,Jimmy Lin,12:10,"biology,cancer,disease,DNA,health,epidemiology,innovation,medical research,medicine,TED Fellows,science"
"
","
","
","
","
",A simple new blood test that can catch cancer early,Jimmy Lin,12:10,"biology,cancer,disease,DNA,health,epidemiology,innovation,medical research,medicine,TED Fellows,science"
"
											The next time you hear the word ""cancer,""
											I want you to add to the emotions: hope.
											Hold on.
											Cancer researchers all around the world
are working feverishly
											to beat this disease,
											and tremendous progress is being made.
									","
											Na próxima vez que ouvirem
a palavra ""cancro"",
											quero que acrescentem
as emoções: a esperança.
											Aguentem.
											Os investigadores do cancro,
no mundo inteiro,
											trabalham freneticamente,
para vencer esta doença
											e estão a ser feitos tremendos avanços.
									","
											La prochaine fois que
vous entendrez le mot « cancer »,
											j'aimerais que vous ajoutiez le mot :
espoir.
											Ayez confiance.
											Les oncologues du monde entier
travaillent avec ferveur
											afin de battre cette maladie,
											et des progrès incroyables 
sont en cours.
									","
											Bir dahaki sefere
""kanser"" kelimesini duyduğunuzda
											Size şu duyguyu hissetirmek istiyorum:
Umut.
											Bekleyin,
											Dünya'nın dört bir yanından kanser 
araştırmacıları bu hastalığı yenmek içim
											çok sıkı çalışıyorlar.
											Muazzam bir gelişme kaydedildi.
									","
											Ich will, dass Sie das nächste Mal, 
wenn Sie das Wort ""Krebs"" hören,
											""Hoffnung"" zu den Gefühlen zu ergänzen.
											Halten Sie durch.
											Krebsforscher auf der ganzen Welt 
arbeiten fieberhaft daran,
											diese Erkrankung zu besiegen,
											und es werden gewaltige 
Fortschritte gemacht.
									",A simple new blood test that can catch cancer early,Jimmy Lin,12:10,"biology,cancer,disease,DNA,health,epidemiology,innovation,medical research,medicine,TED Fellows,science"
"
","
","
","
","
",A simple new blood test that can catch cancer early,Jimmy Lin,12:10,"biology,cancer,disease,DNA,health,epidemiology,innovation,medical research,medicine,TED Fellows,science"
"
											This is the beginning of the end.
											We will win the war on cancer.
											And to me, this is amazing news.
									","
											Isto é o princípio do fim.
											Havemos de ganhar a guerra ao cancro.
											Quanto a mim, é uma notícia espantosa.
									","
											C'est le début de la fin.
											Nous gagnerons la guerre contre le cancer.
											Et pour moi, c'est 
une nouvelle incroyable.
									","
											Bu sonun başlangıcı.
											Kanserle olan savaşımızı kazanacağız.
											Benim için bunlar harika haberler.
									","
											Das ist der Anfang vom Ende.
											Wir werden den Kampf 
gegen den Krebs gewinnen.
											Und ich finde, 
das sind großartige Nachrichten.
									",A simple new blood test that can catch cancer early,Jimmy Lin,12:10,"biology,cancer,disease,DNA,health,epidemiology,innovation,medical research,medicine,TED Fellows,science"
"
","
","
","
","
",A simple new blood test that can catch cancer early,Jimmy Lin,12:10,"biology,cancer,disease,DNA,health,epidemiology,innovation,medical research,medicine,TED Fellows,science"
"
											Thank you.
									","
											Obrigado.
									","
											Merci.
									","
											Teşekkür ederim.
									","
											Vielen Dank.
									",A simple new blood test that can catch cancer early,Jimmy Lin,12:10,"biology,cancer,disease,DNA,health,epidemiology,innovation,medical research,medicine,TED Fellows,science"
"
","
","
","
","
",A simple new blood test that can catch cancer early,Jimmy Lin,12:10,"biology,cancer,disease,DNA,health,epidemiology,innovation,medical research,medicine,TED Fellows,science"
"
											(Applause)
									","
											(Aplausos)
									","
											(Applaudissements)
									","
											(Alkışlar)
									","
											(Applaus)
									",A simple new blood test that can catch cancer early,Jimmy Lin,12:10,"biology,cancer,disease,DNA,health,epidemiology,innovation,medical research,medicine,TED Fellows,science"
"
","
","
","
","
",A simple new blood test that can catch cancer early,Jimmy Lin,12:10,"biology,cancer,disease,DNA,health,epidemiology,innovation,medical research,medicine,TED Fellows,science"
